Stay updated on Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.

Latest updates to the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedRevision note updated from v3.2.0 to v3.3.2. There are no user-facing changes to the study details.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding lapse notice and operating-status information (including links to cc.nih.gov and opm.gov) has been removed from the page. This notice previously informed users about potential delays and where to check status updates.SummaryDifference0.4%

- Check43 days agoChange DetectedNo significant additions or deletions were detected; core study information (title, purpose, eligibility, endpoints) and the page’s primary functions remain unchanged.SummaryDifference0.4%

- Check72 days agoChange Detected- Added a government-operating-status notice and a new medical term; - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check79 days agoChange DetectedUpdate: version bumped from v3.0.2 to v3.1.0, indicating a new release. No other content changes are indicated.SummaryDifference0.1%

- Check94 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent Respiratory Papilloma Clinical Trial page.